Novartis AG (NVS)
NYSE
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 117.45B | 112.24B | 110.98B | 112.7B | 99.95B | 94.33B | 97.51B | 103.52B |
流動資産合計 | 36.91B | 32.11B | 33.49B | 45.66B | 30.48B | 26.45B | 25.69B | 31.26B |
現金および同等物 | 7.52B | 12B | 10.89B | 12.41B | 13.39B | 9.47B | 7.9B | 13.61B |
非流動資産合計 | 89.88B | 78.62B | 76.03B | 65.74B | 77.57B | 66.55B | 70.44B | 70.81B |
負債合計 | 58.03B | 60.1B | 59.05B | 74.45B | 53.2B | 54.58B | 55.6B | 60.08B |
流動負債合計 | 28.66B | 30.55B | 31.91B | 48.39B | 26.39B | 29.29B | 27.61B | 28.13B |
非流動負債合計 | 51.16B | 51.54B | 46.94B | 45.58B | 46.84B | 44.01B | 49.21B | 57.3B |
普通株 | 890M | 842M | 842M | 825M | 825M | 793M | 793M | 793M |
留保所得 | 63.54B | 56.09B | 55.68B | 42.33B | 49.65B | 43.83B | 45.84B | 46.29B |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 130.12B | 133.08B | 145.56B | 118.37B | 132.06B | 131.8B | 117.45B | 99.95B |
流動資産合計 | 24.93B | 28.21B | 35.56B | 29.5B | 29.67B | 45.72B | 36.91B | 30.48B |
現金および同等物 | 7.01B | 8.86B | 13.27B | 11.11B | 9.66B | 12.41B | 7.52B | 13.39B |
非流動資産合計 | 74.89B | 74.23B | 78.69B | 55.55B | 56.67B | 67.82B | 59.42B | 46.75B |
負債合計 | 55.23B | 58.85B | 66.87B | 62.82B | 75.39B | 63.97B | 58.03B | 53.2B |
流動負債合計 | 22.21B | 23.4B | 29.61B | 28.26B | 33.06B | 30.21B | 28.66B | 26.39B |
非流動負債合計 | 50.92B | 58.67B | 59.73B | 56.61B | 70.31B | 58.29B | 51.16B | 46.84B |
総資本 | 74.89B | 74.23B | 78.69B | 55.55B | 56.67B | 67.82B | 59.42B | 46.75B |
普通株 | 972M | 969M | 944M | 936M | 913M | 901M | 890M | 825M |
留保所得 | 73.94B | 73.3B | 82.19B | 59.28B | 57.16B | 70.99B | 63.54B | 49.65B |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約